opinion was taken and she was started on Caspofungin, in view of her immune-suppressed state. Sputum culture revealed Colistin Only Sensitive (COS) Acinetobacter Baumanii. On POD 14 it was noted that she had a white raised plaque on the tongue (Fig. 1) . The plaque was adherent to the tongue and could not be scraped off. Dermatologist's opinion was oral candidiasis, hyperplastic variant. Scrapings were taken from the lesion and sent for KOH mount and fungal cultures. Anti-fungals (Flucanozole orally 400 mg OD and Clotrimazole mouth paint Q6 hourly) were started. KOH mount showed pseudohyphae and spores, suggestive of Candida. Initial culture reports grew Candida species. On POD 19 the plaque started reducing in size ( Fig. 2 ). On POD 20 it had reduced considerably.
Patient's general condition improved over the next 2 weeks and she was discharged and sent home for follow up on OPD basis.
Discussion
Oral candidiasis/candidosis (OC) in renal transplant patients is quite frequent. The prevalence is variable but it ranges between 9.4% and 46%. 1 There are considered to be six variants of OC: acute pseudo-membranous (thrush), acute atrophic (erythematous), chronic atrophic, chronic hyperplastic candidosis (CHC), median rhomboid glossitis and chronic mucocutaneous. 2 Of these, only the first two are seen quite commonly. It has been suggested 3 that these disorders be grouped into two distinct entities-the first (Group I) involving the oral mucosa alone and the second (Group II) with lesions in other extra-oral sites as well. The latter are generally seen in rare inherited immune disorders, starting in childhood, while the former are adult-onset. OC occurs very frequently in immunosuppressed patients due to various reasons. Up to 50% of the population harbor it as a commensal, and a change in local environment predisposes to an increased tendency to clinical manifestations. OC typically occurs when there is a modification of three general factors. They are: (1) Decreased immune status of the patient. (2) Change in oral mucosal environment. 3 A different strain of Candida albicans. 4 Candidiasis appearing as a leukoplakic patch in the oral mucosa has been recognized since the mid-60s. 5, 6 The most common and classic clinical presentation of CHC is a white plaque that cannot be rubbed off and presenting most frequently in the commissural regions of the oral mucosa, infrequently other oral sites can be affected. The initial terminology for this was Candidial leukoplakia (CL), which continued despite the term chronic hyperplastic candidiasis (CHC) also being used in a similar context. CL affects the following oral sites in decreasing order of frequency: the buccal commissures, cheeks, palate, and the tongue. CHC requires to be recognized as a distinctive, though rare entity, because it is frequently misdiagnosed as leukoplakia. According to a WHO definition, 7 leukoplakia is a white patch on mucosal surfaces which cannot be rubbed off, or characterized clinically or pathologically as any other disease. CHC can be recognized as a separate entity from leukoplakia, as only about 10% of the latter fulfill the clinical and histological criteria laid down. 8 Epidemiological factors which have been identified as important in the pathogenesis of CHC include local factors such as xerostomia and dentures, smoking and tobacco chewing, nutritional factors such as deficiencies of various vitamins, Blood group O, Diabetes mellitus and immunological deficiencies against Candida. 3 Clinically, CHC usually presents as a whitish plaque with a homogeneous surface, although a speckled or nodular variant, with interspersed erythematous specks or nodules has been described, especially in CHC of the commissural area. 9 The histopathology may not be specific enough for a diagnosis, unless there is the presence of neutrophilic collections in the sub-corneal location, termed as Munro's micro-abscesses along with candidial hyphae in the upper layers of the epidermis. Culture of Candida species on Sabouraud's dextrose agar should be possible in the majority of cases of CHC, through swabs, smears or washings. The hyperplasic response of the epidermis is considered to be a protective response to a possible deeper invasion by Candida.
The treatment options are either medical or surgical. 10 Antifungal therapy or topical application of 0.18% iso-retinoids, bleomycin, beta carotene or mixed tea. Surgical options include cold-knife surgery, laser therapy and cryosurgery. There is no clinical consensus as to the right treatment, starting noninvasively would be the ideal management.
Our patient had a lesion suggestive of homogeneous CHC, which responded well to treatment. She had multiple predisposing factors such as immune-suppression, xerostomia (due to prolonged periods on NIV), Diabetes mellitus, CKD and blood group ''O+'' (non-secretor). A poor response to treatment would have warranted a biopsy for the possibility of dysplastic change, which can occur in this entity.
In conclusion, CHC although a rarity and possibly a dangerous condition, if addressed early, is completely amenable to treatment.
